pamidronate has been researched along with olpadronic acid in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 15 (48.39) | 18.2507 |
| 2000's | 12 (38.71) | 29.6817 |
| 2010's | 3 (9.68) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, BN; Caldera, A; Croft, SL; Docampo, R; Grimley, JS; Heath, HT; Kendrick, H; Lewis, JC; Lira, R; Martin, MB; Moreno, SN; Oldfield, E; Urbina, JA; Yardley, V | 1 |
| Burzynska, A; Croft, SL; de Luca-Fradley, K; Grimley, JS; Kafarski, P; Kendrick, H; Lewis, JC; Martin, MB; Meints, GA; Oldfield, E; Olsen, JR; Sanders, JM; Van Brussel, EM | 1 |
| Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L | 1 |
| Bruchhaus, I; Chan, JM; Croft, SL; Flessner, RM; Ghosh, S; Kemp, RG; Kendrick, H; Kobayashi, S; Lea, CR; Lewis, JC; Loftus, TC; Meints, GA; Nozaki, T; Oldfield, E; Tovian, ZS | 1 |
| Burzynska, A; Chan, JM; Colantino, A; Ghosh, S; Kafarski, P; Meints, G; Morita, CT; Oldfield, E; Raker, AM; Sanders, JM; Song, Y; Wang, H | 1 |
| Craig, SP; Delfino, JM; Fernández, D; Wenck, MA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Alblas, MJ; Bijvoet, OL; de Groot, H; Löwik, CW; Papapoulos, SE; van der Pluijm, G; van der Wee-Pals, LJ | 1 |
| Hoekman, K; Papapoulos, SE; Tjandra, YI | 1 |
| Keppler, BK; Klenner, T; Krempien, B; Schmähl, D; Wingen, F | 1 |
| Breedveld, FC; Lafeber, GJ; Markusse, HM | 1 |
| Bijvoet, OL; Hoekman, K; Löwik, CW; Papapoulos, SE; Vermeij, P | 1 |
| Mautalen, C; Pérez Lloret, A; Roldán, EJ; Vega, E | 1 |
| Bijvoet, OL; Papapoulos, SE; Schweitzer, DH; Vermeij, P; Zwinderman, AH | 1 |
| den Hartigh, J; Sparidans, RW; Vermeij, P | 1 |
| Löwik, C; Papapoulos, S; Que, I; Van Beek, E | 1 |
| Brown, RJ; Löwik, CW; Papapoulos, SE; van Beek, E; Watts, DJ | 1 |
| Mondelo, N; Montuori, E; Parma, MD; Peluffo, VA; Piccinni, E; Zanchetta, JR | 1 |
| González, D; Mautalen, C; Pastrana, M | 1 |
| Cohen, L; Löwik, C; Papapoulos, S; Pieterman, E; van Beek, E | 1 |
| Haber, B; Sentongo, TA | 1 |
| Den Hartigh, J; Pas, O; Ramp-Koopmanschap, W; Twiss, IM; Vermeij, P | 1 |
| Bellido, T; Manolagas, SC; Parfitt, AM; Plotkin, LI; Roberson, PK; Weinstein, RS | 1 |
| Berenson, J; Hortobagyi, G; Lipton, A; Major, PP | 1 |
| Mautalen, CA; Oliveri, MB; Parisi, MS | 1 |
| Bellido, T; Leoni, J; Mathov, I; Plotkin, LI; Sgarlata, CL | 1 |
| Gomez-Acotto, C; Mautalen, C; Zeni, S | 1 |
| Bosch, JJ; Burggraaf, J; Cohen, AF; de Kam, ML; Twiss, IM; van den Berk, AH; Vermeij, P | 1 |
| Burton, DW; Deftos, LJ; Geller, J; Hastings, RH; Hillegonds, DJ; Hoffman, RM; Yang, M | 1 |
| de Jong, E; Hamdy, NA; Kuijpers, SC; van Merkesteyn, JP | 1 |
| Roldán, EJ | 1 |
1 review(s) available for pamidronate and olpadronic acid
| Article | Year |
|---|---|
Oral bisphosphonates: A review of clinical use in patients with bone metastases.
Topics: Alendronate; Biological Availability; Bone Density; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Double-Blind Method; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Male; Multiple Myeloma; Pamidronate; Prostatic Neoplasms; Pyridines; Randomized Controlled Trials as Topic; Risedronic Acid; Zoledronic Acid | 2000 |
2 trial(s) available for pamidronate and olpadronic acid
| Article | Year |
|---|---|
Preliminary study of multiple increasing oral doses of dimethyl-APD on bone metabolism dynamics and safety profile.
Topics: Aged; Alkaline Phosphatase; Body Temperature; Bone and Bones; Calcium; Diphosphonates; Ergocalciferols; Humans; Hydroxyproline; Male; Middle Aged; Osteitis Deformans; Pamidronate; Tablets, Enteric-Coated | 1994 |
A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans.
Topics: Adult; Alendronate; Bone Density Conservation Agents; Cross-Over Studies; Diphosphonates; Female; Gastrointestinal Diseases; Humans; Pamidronate; Single-Blind Method | 2006 |
28 other study(ies) available for pamidronate and olpadronic acid
| Article | Year |
|---|---|
Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.
Topics: Animals; Antiprotozoal Agents; Chlorocebus aethiops; Diphosphonates; Leishmania donovani; Plasmodium falciparum; Structure-Activity Relationship; Toxoplasma; Trypanosoma brucei brucei; Trypanosoma cruzi; Vero Cells | 2001 |
Activity of bisphosphonates against Trypanosoma brucei rhodesiense.
Topics: Animals; Crystallography, X-Ray; Diphosphonates; Humans; Lethal Dose 50; Models, Molecular; Quantitative Structure-Activity Relationship; Quantum Theory; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Tumor Cells, Cultured | 2002 |
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).
Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques; Kidney; Mice; Pamidronate; Parathyroidectomy; Rats; Skull; Structure-Activity Relationship; Thyroidectomy; Zoledronic Acid | 2002 |
Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Cell Line; Cricetinae; Diphosphonates; Entamoeba histolytica; Entamoebiasis; Humans; In Vitro Techniques; Liver Abscess; Malaria; Mice; Mice, Inbred BALB C; Plasmodium berghei; Plasmodium falciparum; Structure-Activity Relationship | 2004 |
Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.
Topics: Alkyl and Aryl Transferases; Animals; Cell Division; Cell Line; Diphosphonates; Geranyltranstransferase; Humans; Leishmania major; Lymphocyte Activation; Models, Molecular; Quantitative Structure-Activity Relationship; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2004 |
The purine transferase from Trypanosoma cruzi as a potential target for bisphosphonate-based chemotherapeutic compounds.
Topics: Animals; Diphosphonates; Drug Delivery Systems; Pentosyltransferases; Trypanosoma cruzi | 2004 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants.
Topics: Animals; Bone Resorption; Calcium; Clodronic Acid; Culture Techniques; Diphosphonates; Dose-Response Relationship, Drug; Drug Synergism; Female; Mice; Mice, Inbred Strains; Pamidronate; Parathyroid Hormone; Pregnancy | 1991 |
The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein.
Topics: Aged; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Female; Humans; Hypercalcemia; Ovarian Neoplasms; Pamidronate; Paraneoplastic Endocrine Syndromes; Parathyroid Hormone-Related Protein; Proteins | 1991 |
Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: a promising perspective in the treatment of bone-related malignancies?
Topics: Animals; Bone and Bones; Bone Neoplasms; Carcinoma 256, Walker; Diphosphonates; Drug Evaluation, Preclinical; Organophosphorus Compounds; Organoplatinum Compounds; Osteosarcoma; Pamidronate; Rats | 1990 |
Bisphosphonates in collagen arthritis.
Topics: Animals; Antibodies; Arthritis; Collagen; Diphosphonates; Female; Pamidronate; Radiography; Rats; Rats, Inbred Strains | 1990 |
Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphosphonate.
Topics: Administration, Oral; Aged; Animals; Bone and Bones; Bone Resorption; Clinical Protocols; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Mice; Middle Aged; Models, Biological; Organ Culture Techniques; Osteitis Deformans; Pamidronate; Prospective Studies | 1989 |
Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone Resorption; Diphosphonates; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Remission Induction | 1993 |
High-performance ion-exchange chromatography with in-line complexation of bisphosphonates and their quality control in pharmaceutical preparations.
Topics: Chromatography, Ion Exchange; Copper; Diphosphonates; Pamidronate; Potentiometry; Quality Control; Spectrophotometry, Ultraviolet; Tablets | 1995 |
Dissociation of binding and antiresorptive properties of hydroxybisphosphonates by substitution of the hydroxyl with an amino group.
Topics: Amines; Analysis of Variance; Animals; Binding Sites; Bone Matrix; Bone Resorption; Calcium Oxalate; Crystallization; Diphosphonates; Etidronic Acid; Female; Mice; Pamidronate; Pregnancy; Structure-Activity Relationship | 1996 |
Differential effects of aminosubstituted analogs of hydroxy bisphosphonates on the growth of Dictyostelium discoideum.
Topics: Amines; Animals; Bone Density; Bone Resorption; Dictyostelium; Diphosphonates; Dose-Response Relationship, Drug; Etidronic Acid; Female; Hindlimb; Mice; Pamidronate; Structure-Activity Relationship | 1998 |
[Experimental effects of olpadronate and pamidronate on bone mass].
Topics: Analysis of Variance; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Female; Male; Ovariectomy; Pamidronate; Rats; Rats, Wistar | 1997 |
[Treatment of Paget's disease with olpadronate. Its efficacy in partial responders to oral pamidronate].
Topics: Aged; Diphosphonates; Drug Tolerance; Female; Humans; Male; Osteitis Deformans; Pamidronate; Retrospective Studies; Treatment Outcome | 1997 |
Nitrogen-containing bisphosphonates inhibit isopentenyl pyrophosphate isomerase/farnesyl pyrophosphate synthase activity with relative potencies corresponding to their antiresorptive potencies in vitro and in vivo.
Topics: Animals; Bone Resorption; Brain; Carbon-Carbon Double Bond Isomerases; Cattle; Clodronic Acid; Dimethylallyltranstransferase; Diphosphonates; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Hemiterpenes; Ibandronic Acid; Mice; Multienzyme Complexes; Nitrogen; Pamidronate | 1999 |
Progress in the prevention and treatment of osteoporosis in pediatrics.
Topics: Adolescent; Bone Density; Child; Diphosphonates; Humans; Osteoporosis; Pamidronate | 1999 |
The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium.
Topics: Alendronate; Apoptosis; Caco-2 Cells; Calcium; Cell Survival; Diphosphonates; Epithelial Cells; Humans; Intestinal Mucosa; Models, Biological; Nitrogen; Pamidronate; Solubility; Structure-Activity Relationship | 1999 |
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.
Topics: Alendronate; Animals; Apoptosis; Calcitonin; Cell Line; Cells, Cultured; Dexamethasone; Diphosphonates; Etidronic Acid; Etoposide; In Situ Nick-End Labeling; Mice; Osteoblasts; Osteocytes; Pamidronate; Prednisolone; Skull; Tumor Necrosis Factor-alpha | 1999 |
Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia.
Topics: Absorptiometry, Photon; Adult; Bone Density; Diphosphonates; Female; Fibrous Dysplasia, Polyostotic; Humans; Pamidronate; Time Factors | 2001 |
Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro.
Topics: Animals; Calcium Channel Blockers; Calcium Channels; Cell Division; Cell Line; Cells, Cultured; Diphosphonates; Enzyme Activation; Etidronic Acid; Kinetics; Mitogen-Activated Protein Kinases; Nifedipine; Osteoblasts; Pamidronate; Phosphorylation; Rats | 2001 |
Do different aminobisphosphonates have similar preventive effect on experimental thyroid hormone-induced osteopenia in rats?
Topics: Alendronate; Animals; Body Weight; Bone Diseases, Metabolic; Diphosphonates; Female; Pamidronate; Rats; Rats, Sprague-Dawley; Thyroxine | 2001 |
The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Calcium; Cell Line, Tumor; Diphosphonates; Disease Progression; Glycoproteins; Green Fluorescent Proteins; Humans; Male; Mice; Mice, Nude; Osteoprotegerin; Pamidronate; Parathyroid Hormone-Related Protein; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Time Factors; Treatment Outcome; Xenograft Model Antitumor Assays | 2006 |
Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates.
Topics: Adult; Aged; Analgesics; Bone Density Conservation Agents; Child; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Mandibular Diseases; Middle Aged; Osteomyelitis; Pamidronate; Radionuclide Imaging; Recurrence; Sclerosis; Treatment Outcome; Young Adult; Zoledronic Acid | 2011 |
[Pamidronate and olpadronate discoverer, Prof. Olav Maria Leonard Bijvoet passed away].
Topics: Bone Density Conservation Agents; Diphosphonates; History, 20th Century; History, 21st Century; Pamidronate | 2014 |